Pasithea Therapeutics KTTA
NASDAQ KTTA
$0.49 0.00 (-0.79%)
At close: Oct 1, 2026 · 4:00 PM EDT

Pasithea Therapeutics (KTTA) Other financing activities (2025)

Updated

Pasithea Therapeutics' Other financing activities was $39,310 in Q4 2025, down 66.2% from the prior quarter.

Analysis

Pasithea Therapeutics (KTTA) Other financing activities (2025) Analysis & Trends

For FY2025, Other financing activities at Pasithea Therapeutics came in at $448,279.

  • Per Business Quant data, KTTA's Other financing activities in the three quarters before Q4 2025 was $116,145 (Q3 2025), $113,514 (Q2 2025) and $179,310 (Q1 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Pasithea Therapeutics 16.37 Mn 16.37 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 39,310.00
Sep 30, 2025 116,145.00
Jun 30, 2025 113,514.00
Mar 31, 2025 179,310.00
API Access

Pasithea Therapeutics Other financing activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=KTTA&period=max&api_key=YOUR_API_KEY